ATE393781T1 - Somatostatin analoge, deren radiomarkierte derivate und deren verwendung - Google Patents

Somatostatin analoge, deren radiomarkierte derivate und deren verwendung

Info

Publication number
ATE393781T1
ATE393781T1 AT00992965T AT00992965T ATE393781T1 AT E393781 T1 ATE393781 T1 AT E393781T1 AT 00992965 T AT00992965 T AT 00992965T AT 00992965 T AT00992965 T AT 00992965T AT E393781 T1 ATE393781 T1 AT E393781T1
Authority
AT
Austria
Prior art keywords
somatostatin
compounds
radiom
diagnosing
labeled derivatives
Prior art date
Application number
AT00992965T
Other languages
English (en)
Inventor
John Lister-James
Richard Dean
Daniel Pearson
David Wilson
Original Assignee
Xanthus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xanthus Pharmaceuticals Inc filed Critical Xanthus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE393781T1 publication Critical patent/ATE393781T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT00992965T 1999-08-27 2000-08-23 Somatostatin analoge, deren radiomarkierte derivate und deren verwendung ATE393781T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15100199P 1999-08-27 1999-08-27
US09/397,792 US6358491B1 (en) 1999-08-27 1999-09-16 Somatostatin analogs

Publications (1)

Publication Number Publication Date
ATE393781T1 true ATE393781T1 (de) 2008-05-15

Family

ID=26848228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00992965T ATE393781T1 (de) 1999-08-27 2000-08-23 Somatostatin analoge, deren radiomarkierte derivate und deren verwendung

Country Status (12)

Country Link
US (1) US6358491B1 (de)
EP (1) EP1208116B1 (de)
JP (1) JP2003517037A (de)
AT (1) ATE393781T1 (de)
AU (1) AU782873B2 (de)
CA (1) CA2383936A1 (de)
CO (1) CO5460266A1 (de)
DE (1) DE60038739T2 (de)
ES (1) ES2305000T3 (de)
PE (1) PE20010516A1 (de)
TW (1) TWI243178B (de)
WO (1) WO2001044177A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0961591B1 (de) * 1997-11-24 2008-05-14 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe
EP1283216A1 (de) * 2001-08-10 2003-02-12 Mallinckrodt Inc. Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung
DE10215336A1 (de) 2002-03-28 2003-10-23 Schering Ag N-Methyl-Homocysteine und ihre Verwendung sowie Verfahren zu ihrer Herstellung
WO2003057214A1 (en) * 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
EP2474328A3 (de) * 2003-09-17 2012-07-18 Board Of Regents, The University Of Texas System Mechanismusbasierte gezielte pankreatische Betazellenabbildung und Behandlung
EP1700608A1 (de) 2005-03-10 2006-09-13 Schering AG Chelate für radioaktiv markierte Konjugate mit einer stabilisierenden Seitenkette
WO2006094725A1 (en) * 2005-03-10 2006-09-14 Bayer Schering Pharma Aktiengesellschaft Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
EP1717219A1 (de) * 2005-04-28 2006-11-02 Schering AG Orthogonal geschützte bifunktionelle Aminosäure
WO2006114324A1 (en) * 2005-04-28 2006-11-02 Schering Ag Compounds comprising cyclized somatostatin receptor binding peptides
EP1717247A1 (de) * 2005-04-28 2006-11-02 Schering AG Zyklische Peptide, die sich am Somatostatinrezeptor binden
US20070025910A1 (en) * 2005-07-29 2007-02-01 Norenberg Jeffrey P Anticancer therapy
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
RU2528414C1 (ru) * 2013-01-25 2014-09-20 Закрытое Акционерное Общество "Фарм-Синтез" Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
CN105431447A (zh) * 2013-03-15 2016-03-23 阿达拉塔合伙有限公司 Pcsk9的小分子调节剂和其使用方法
EP3160518A4 (de) * 2014-06-30 2018-05-23 Tarveda Therapeutics, Inc. Gerichtete konjugate sowie partikel und formulierungen davon
AU2016343817B2 (en) 2015-10-28 2021-05-27 Tva (Abc), Llc SSTR-targeted conjugates and particles and formulations thereof
PT3568205T (pt) 2017-01-12 2023-10-26 Radiomedix Inc Tratamento de células de cancro que sobrexpressam recetores de somatostatina com a utilização de derivados de ocreótido quelado a radioisótopos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310518A (en) 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4486415A (en) 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4522813A (en) 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
EP0222578A3 (de) 1985-11-06 1990-04-04 Merck & Co. Inc. Verwendung von cyclischen Somatostatinanaloga zur Behandlung von sofortigen Überempfindlichkeitskrankheiten
US5776894A (en) 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5985240A (en) 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
ES2158897T3 (es) * 1993-06-23 2001-09-16 Diatide Inc Peptidos radiomarcados derivados de somatostatina y utilizados en procedimientos de formacion de imagenes y terapeuticos.
GB9417873D0 (en) 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5597894A (en) 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5770687A (en) 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US5830431A (en) 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
MY147327A (en) 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
US5708135A (en) 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
AT405906B (de) 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Also Published As

Publication number Publication date
AU782873B2 (en) 2005-09-08
TWI243178B (en) 2005-11-11
JP2003517037A (ja) 2003-05-20
WO2001044177A2 (en) 2001-06-21
EP1208116A2 (de) 2002-05-29
DE60038739D1 (de) 2008-06-12
CA2383936A1 (en) 2001-06-21
US6358491B1 (en) 2002-03-19
PE20010516A1 (es) 2001-04-29
EP1208116B1 (de) 2008-04-30
ES2305000T3 (es) 2008-11-01
DE60038739T2 (de) 2009-05-20
WO2001044177A3 (en) 2002-03-28
AU4865901A (en) 2001-06-25
CO5460266A1 (es) 2004-11-30

Similar Documents

Publication Publication Date Title
ATE393781T1 (de) Somatostatin analoge, deren radiomarkierte derivate und deren verwendung
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
CY1105879T1 (el) Αζαδικυκλο παραγωγα ως ανταγωνιστες μουσκαρινικου υποδοχεα
NO20022655D0 (no) <Beta>-2-adrenerge reseptoragonister
ATE480252T1 (de) Peptidantagonist von zonulin und dessen verwendung
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
DK1054887T3 (da) Bicykliske pyridin- og pyrimidinderivater som neuropeptid Y-receptorantagonister
BR0208179A (pt) Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto
AUPO755097A0 (en) Receptor agonist and antagonist
EA200400816A1 (ru) Замещенные аналоги хиназолин-4-иламина в качестве модуляторов капсаицина
DE69728585D1 (de) Mittel gegen Juckreiz
EP1383919A4 (de) Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor
HK1082200A1 (en) Compositions and methods for the therapy of inflammatory bowel disease
EP1109542A4 (de) Nitrosierte und nitrosylierte antagonisten des alpha-adrenergischen rezeptors, zusammenstellungen und verwendungsmethoden
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
EP1461061A4 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von krankheiten und zuständen im zusammenhang mit chemokine-rezeptoren
DK1085896T3 (da) Somatostatinanaloger cykliseret med konformationelt begrænset skelet
ATE481103T1 (de) Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
ATE356623T1 (de) 5-ht3-rezeptorantagonisten und verwendungsverfahren
ATE429421T1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
NO20002408D0 (no) 5-HT1F antagonister
SE0303418D0 (sv) New use 1
WO2003104395A3 (en) RECEPTORS AND PROTEINS ASSOCIATED WITH A MEMBRANE-
SE0303488D0 (sv) New use 1X

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties